PRIMED CELL THERAPY
본 발명은 감작 연결 조직 세포 및 이의 약제학적으로 허용되는 담체를 포함하는 조성물에 관한 것이다. The subject invention is directed to a composition comprising primed connective tissue cells and a pharmaceutically acceptable carrier thereof.
Saved in:
| Main Authors | , , |
|---|---|
| Format | Patent |
| Language | English Korean |
| Published |
16.07.2019
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | 본 발명은 감작 연결 조직 세포 및 이의 약제학적으로 허용되는 담체를 포함하는 조성물에 관한 것이다.
The subject invention is directed to a composition comprising primed connective tissue cells and a pharmaceutically acceptable carrier thereof. |
|---|---|
| AbstractList | 본 발명은 감작 연결 조직 세포 및 이의 약제학적으로 허용되는 담체를 포함하는 조성물에 관한 것이다.
The subject invention is directed to a composition comprising primed connective tissue cells and a pharmaceutically acceptable carrier thereof. |
| Author | LEE KWAN HEE NOH MOON JONG YI YOUNGSUK |
| Author_xml | – fullname: LEE KWAN HEE – fullname: YI YOUNGSUK – fullname: NOH MOON JONG |
| BookMark | eNrjYmDJy89L5WQQDgjy9HV1UXB29fFRCPFwDXIMiORhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHeQUYGhpYGBhYmxiaGjsbEqQIAkwwg0g |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | 감작 세포 치료요법 |
| ExternalDocumentID | KR20190084341A |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_KR20190084341A3 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 13:58:45 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English Korean |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_KR20190084341A3 |
| Notes | Application Number: KR20197019444 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190716&DB=EPODOC&CC=KR&NR=20190084341A |
| ParticipantIDs | epo_espacenet_KR20190084341A |
| PublicationCentury | 2000 |
| PublicationDate | 20190716 |
| PublicationDateYYYYMMDD | 2019-07-16 |
| PublicationDate_xml | – month: 07 year: 2019 text: 20190716 day: 16 |
| PublicationDecade | 2010 |
| PublicationYear | 2019 |
| RelatedCompanies | KOLON TISSUEGENE, INC |
| RelatedCompanies_xml | – name: KOLON TISSUEGENE, INC |
| Score | 3.1741781 |
| Snippet | 본 발명은 감작 연결 조직 세포 및 이의 약제학적으로 허용되는 담체를 포함하는 조성물에 관한 것이다.
The subject invention is directed to a composition comprising primed connective tissue cells and a... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SPIRITS VINEGAR WINE |
| Title | PRIMED CELL THERAPY |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190716&DB=EPODOC&locale=&CC=KR&NR=20190084341A |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTAxN0gyMU_TTUxKBHZQ0kzTdC0M01KBaRl0WlyyeYpZGmgc0tfPzCPUxCvCNIKJIQe2FwZ8Tmg5-HBEYI5KBub3EnB5XYAYxHIBr60s1k_KBArl27uF2LqoQXvHwNoN2P5Xc3GydQ3wd_F3VnN2tvUOUvMLgsgZWJgAC21HZgZWYEPaHNxtC3MC7UspQK5U3AQZ2AKA5uWVCDEwZecLM3A6w-5eE2bg8IVOeQOZ0NxXLMIgHBDk6evqouDs6uOjEOLhGuQYECnKoOzmGuLsoQs0PR7umXjvIGSnGIsxsAC7-akSDAqWycbJhilpwB6poaWJRaolsOWSkmYC7LmmgU6YT0uRZJDBZ5IUfmlpBi4QFzQqaWgmw8BSUlSaKgusTkuS5MChAABzmHSO |
| link.rule.ids | 230,309,783,888,25577,76883 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMTAxN0gyMU_TTUxKBHZQ0kzTdC0M01KBaRl0WlyyeYpZGmgc0tfPzCPUxCvCNIKJIQe2FwZ8Tmg5-HBEYI5KBub3EnB5XYAYxHIBr60s1k_KBArl27uF2LqoQXvHwNoN2P5Xc3GydQ3wd_F3VnN2tvUOUvMLgsgZWJgAC21HZgZWYCPbAtxZCnMC7UspQK5U3AQZ2AKA5uWVCDEwZecLM3A6w-5eE2bg8IVOeQOZ0NxXLMIgHBDk6evqouDs6uOjEOLhGuQYECnKoOzmGuLsoQs0PR7umXjvIGSnGIsxsAC7-akSDAqWycbJhilpwB6poaWJRaolsOWSkmYC7LmmgU6YT0uRZJDBZ5IUfml5Bk6PEF-feB9PP29pBi6QFGiE0tBMhoGlpKg0VRZYtZYkyYFDBAARnHd- |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PRIMED+CELL+THERAPY&rft.inventor=LEE+KWAN+HEE&rft.inventor=YI+YOUNGSUK&rft.inventor=NOH+MOON+JONG&rft.date=2019-07-16&rft.externalDBID=A&rft.externalDocID=KR20190084341A |